CLINICAL_TRIALS
trial_result
· 2018-07-31
Clinical Trial Update: Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma [Phase 2]
Summary
A Phase 2 clinical trial update on bevacizumab plus nimustine for patients with recurrent glioblastoma. The study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Huashan Hospital | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED